RBC Capital Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $642
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has maintained an Outperform rating on Thermo Fisher Scientific (TMO) and increased the price target from $592 to $642.
February 01, 2024 | 4:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has maintained an Outperform rating on Thermo Fisher Scientific and raised the price target from $592 to $642.
The increase in price target by RBC Capital suggests a strong confidence in Thermo Fisher Scientific's future performance. This endorsement from a reputable analyst is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100